Clinical trial
Evaluation of Genetic Markers as Explanations for the Observed Differences in…
NCT00107029 · University of North Carolina, Chapel Hill, Other · Completed
Key facts
| NCT number | NCT00107029 |
|---|---|
| Title | Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth |
| Official title | Evaluation of HIV-Specific CD8+ T-Cell Responses and Escape Mutations as Explanations for the Observed Differences in Disease Progression Conferred by HLA Class I Alleles |
| Lead sponsor | University of North Carolina, Chapel Hill, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH National Institute of Mental Health (NIMH) National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infection |
| Enrollment | 113 |
| Start date | Dec 1, 2002 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Apr 5, 2005 |
| Last update posted | Feb 28, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: